Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol 0.5% vs desoximetasone 0.25% for chronic hand eczema
TCTR20210704004Phase 3Recruiting
- Sponsor
- Chulabhorn International College of Medicine
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of timolol, desoximetasone in chronic hand dermatitis (CHE), sponsored by Chulabhorn International College of Medicine. Started Jun 2021; status: recruiting.
02
Drugs
timololdesoximetasone
03
Conditions
chronic hand dermatitis (CHE)
Beyond the preview
Go deeper on TCTR20210704004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210704004.